Federal government of the United States

Archive for the ‘Federal government of the United States’ Category

Maker of anthrax vaccine discusses challenges of marketing overseas

Posted by: fuadelhibri on: August 17, 2009

In: Chairman | Chief Executive Officer | Emergent BioSolutions | Emergent BioSolutions Inc. | Federal government of the United States | Fuad El-Hibri | Lansing | Maryland | Rockville | Stock | U.S Government | U.S. Food and Drug Administration
Leave a Comment

BioPort is the only FDA-licensed producer of the anthrax vaccine. Fuad El-Hibri, chairman and CEO of Emergent BioSolutions Inc., speaks March 9 in Sage Hall. Kevin Stearns/University Photography On March 9, MBA students taking International Political Risk Management, a course taught by Elena Iankova, a lecturer at the S.C. Johnson Graduate School of Management, heard [...]

Tags: Business, Chief Executive Officer, Emergent BioSolutions, fuad, Fuad El-Hibri, U.S. Food and Drug Administration, United States, United States Department of Health and Human Services

Fuad El-Hibri on Vox

Posted by: fuadelhibri on: August 17, 2009

Mr. Fuad El-Hibri is the Chairman and Chief Executive Officer of Emergent BioSolutions Inc. (Emergent) family, health, polo, music, telecommunications, telecom, science, technology, banking, mergers, acquisitions, management, academia

Tags: Board of directors, Business, Chief Executive Officer, Emergent BioSolutions, Federal government of the United States, fuad, Fuad El-Hibri, fuad profiles, U.S. Food and Drug Administration, United States Department of Health and Human Services

Emergent Biosolutions Signs $448 Million Three Year Contract With Department Of Health And Human Services

Posted by: fuadelhibri on: August 17, 2009

ROCKVILLE, MD, September 26, 2007—Emergent BioSolutions Inc. (NYSE: EBS), announced today that it has signed a three year contract with the U.S. Department of Health and Human Services (HHS), with a total value of up to $448 million. Components of the contract include: $400 million firm fixed-price for delivery of 18.75 million doses of BioThrax® [...]

Tags: Biomedical Advanced Research and Development Authority, Clinical trial, Emergent BioSolutions, FDA, Federal government of the United States, U.S. Food and Drug Administration, United States, United States Department of Health and Human Services

El-Hibri Fuad Blog

Archive for the ‘Federal government of the United States’ Category

Maker of anthrax vaccine discusses challenges of marketing overseas

Emergent Biosolutions Signs $448 Million Three Year Contract With Department Of Health And Human Services

Search

Categories

Archives

Follow “El-Hibri Fuad Blog”